2. 3. 2017
The Management Board of Krka, d. d., held a press conference presenting to the public the unaudited performance results of the Krka Group and the Krka Company for 2016. President of the Management Board Jože Colarič told the press the Group had sold €1,174.4 million worth of products and services in the reported period. The volume of sales increased by 11%, and the value of sales by 1%. Unaudited Group net profit totalled €108.5 million. Krka Company sales amounted to €1,071.7 million, unaudited net profit totalling €102.9 million. Operating results agree with the forecast published by the Management Board in November 2016.
14. 2. 2017
Beauty is in the eyes of the beholder
Novo mesto, 9 February 2017 – A photo exhibition by Krka employees who participated in the international photo contest was opened at Krka to mark this year's Culture Day. The landscape motifs captured on camera tell the story of successful bringing together Krka employees of different nationalities and cultures.
17. 11. 2016
Novo mesto, 17 November 2016 – In the first nine months of the year the Krka Group sales totalled €852.4 million (down 1%), resulting in €80.3 million of net profit. The Krka Company sales totalled €782.5 million, resulting in €72.4 million of net profit. The Interim Report for the Krka Group and the Krka Company for January–September 2016 was discussed by the Krka Supervisory Board at its yesterday's regular meeting.
28. 7. 2016
The Krka Group sales totalled €603.8 million in the first half of the year (up 1%), resulting in €70.1 million of net profit. Krka Company sales revenues amounted to €539.7 million, resulting in €56.2 million of net profit.
7. 7. 2016
Otočec, 7 July 2016 – Krka, tovarna zdravil, d. d., Novo mesto held its 22nd Annual General Meeting today in Hotel Šport in Otočec, Slovenia. Shareholders were acquainted with the Management Board annual report for the business year 2015, including remuneration of the Management Board (MB) and Supervisory Board (SB), the auditor's report, and the report of the SB on its verification and approval of the 2015 annual report. In addition to other business, shareholders deliberated on the allocation of accumulated profit for 2015, deciding to pay a gross dividend of €2.65 per share, which is an increase by 6% from last year. They also elected a new SB member, Dr Boris Žnidarič, his term-in-office having commenced as at the day of election at the AGM.